Se espera que el mercado mundial de pruebas de fertilidad crezca a una tasa anual compuesta del 6,85 % entre 2020 y 2029. Se espera que alcance más de 980 millones de USD en 2029 desde 540 millones de USD en 2020.
La expansión de este mercado está impulsada principalmente por varios factores, entre ellos la tendencia ascendente en la edad del primer embarazo entre las mujeres, las tasas de fertilidad en descenso observadas tanto en hombres como en mujeres, la creciente incidencia de trastornos como el síndrome de ovario poliquístico (SOP), el advenimiento de tecnologías avanzadas de monitoreo de la ovulación y una mayor conciencia con respecto a las pruebas de fertilidad en los países desarrollados y en desarrollo.
Cabe destacar que economías en auge como China, India, Brasil y México presentan vías prometedoras para el crecimiento dentro del sector de las pruebas de fertilidad. La demanda de dispositivos de monitoreo de la fertilidad y la ovulación en los mercados emergentes está lista para presenciar un aumento sustancial en los próximos años, impulsada por las crecientes tasas de infertilidad, una prevalencia creciente de enfermedades como el síndrome de ovario poliquístico y la obesidad, la expansión de las iniciativas para la educación sobre fertilidad y la accesibilidad conveniente de las herramientas de monitoreo de la fertilidad a través de plataformas en línea , farmacias y establecimientos minoristas.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Millones de USD |
| Segmentación | Por tipo, aplicación y usuario final |
| Por tipo |
|
| Por aplicación |
|
| Por el usuario final |
|
| Por región |
|
El panorama regulatorio global que rige el mercado de pruebas de fertilidad se caracteriza por la supervisión de agencias regulatorias prominentes como la Administración de Alimentos y Medicamentos (FDA) en los Estados Unidos, la Agencia Europea de Medicamentos (EMA) en la Unión Europea y Health Canada en Canadá, entre otras. Los productos de pruebas de fertilidad generalmente caen dentro de la clasificación de dispositivos de diagnóstico in vitro (IVD) y están sujetos a rigurosos procedimientos de aprobación o autorización previa a la comercialización, lo que garantiza el cumplimiento de rigurosos estándares de seguridad, eficacia y calidad. Los fabricantes deben navegar a través de diversas vías regulatorias, como el proceso de autorización 510(k) de la FDA, el marcado CE de acuerdo con el Reglamento de Dispositivos Médicos de Diagnóstico In Vitro (IVDR) en la UE y la adquisición de una Licencia de Dispositivo Médico (MDL) de Health Canada, para facilitar la penetración en el mercado global de sus productos.
The fertility test market size had crossed USD 0.54 Billion in 2020 and will observe a CAGR of more than 6.85% up to 2027.
Product launches and approvals, agreements and partnerships, expansions, and acquisitions are among the primary growth tactics employed by the market's leading companies.
The high cost of fertility testing monitors is projected to be the key factor limiting the growth of the fertility test industry.
The global fertility test market registered a CAGR of 6.85% from 2022 to 2029.
Key players profiled in the report include Church and Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products Inc., Prestige Brands Holdings Inc., Quidel Corporation, Abbott Laboratories, UEBE Medical, Advocare Pharma.
The female fertility testing sector is projected to be the fastest-growing segment in the fertility test market.
North America is the largest regional market for the fertility test market.
On the basis of type, the fertility test market is segmented into ovulation prediction kits, fertility monitors, urine-based ovulation test kits, saliva-based ovulation test kits, other fertility monitors, and male fertility test kits. Fertility monitors are further classified as urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors. Due to the increased usage of ovulation prediction kits and the simple availability of over-the-counter test kits for at-home testing, the ovulation prediction kits segment is the largest contributor to market growth.
Based on application, the fertility test market is divided into female fertility testing and male fertility testing. Due to the availability of a wide range of fertility testing products for females, technologically developed testing kits that predict correct ovulation date, and declining female fertility rates, the female fertility testing sector accounted for the majority of the market share.
On the basis of End-Use, the fertility test market is divided into home care settings, and fertility clinics. Because of the change in patients toward self-monitoring of healthcare issues and the simple availability of the user-friendly benefit of at-home test devices, home care settings are predicted to dominate the fertility test market. Companies are releasing ovulation prediction kits that may be used at home to evaluate the hormone present in the saliva or urine required for ovulation.
[caption id="attachment_9457" align="alignleft" width="680"]
These key players include Church and Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products Inc., Prestige Brands Holdings Inc., Quidel Corporation, Abbott Laboratories, UEBE Medical, Advocare Pharma, and others.
Companies are mainly in fertility test they are competing closely with each other. Innovation is one of the most important key strategies as it has to be for any market. However, companies in the market have also opted for and successfully driven inorganic growth strategies like mergers & acquisitions, and so on.
The fertility test market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
Its major share is occupied by North America, Asia Pacific, Middle East & Africa (MEA), and Europe region. The North America shares 39% of the total market.
[caption id="attachment_9458" align="alignleft" width="680"]
9.1. Iglesia y Dwight Co. Inc.
9.2. Salud Fairhaven LLC
9.3. Enfoque en la fertilidad limitada
9.4. Geratherm Medical AG
9.5. Productos HiLin Life Inc.
9.6. Prestige Brands Holdings Inc.
9.7 Corporación Quidel
9.8. Laboratorios Abbott
9.9. UEBE Médica
9.10. Advacare Pharma *La lista de empresas es indicativa
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.